Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Pesek

Concepts (132)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enteritis
10
2023
18
4.890
Why?
Gastritis
10
2023
31
4.810
Why?
Eosinophilic Esophagitis
11
2024
34
4.090
Why?
Eosinophilia
9
2023
35
3.930
Why?
Eosinophils
4
2024
38
1.980
Why?
Desensitization, Immunologic
6
2022
107
1.930
Why?
Colitis
2
2019
51
1.310
Why?
Allergens
4
2024
139
0.920
Why?
Endoscopy, Gastrointestinal
3
2022
73
0.770
Why?
Hypersensitivity
2
2023
77
0.770
Why?
Molecular Targeted Therapy
2
2019
119
0.750
Why?
Anaphylaxis
2
2018
71
0.730
Why?
Gastroenteritis
1
2019
17
0.680
Why?
Gastrointestinal Agents
1
2019
34
0.670
Why?
Esophagus
3
2024
84
0.660
Why?
Acetazolamide
1
2018
19
0.630
Why?
Pseudotumor Cerebri
1
2018
24
0.620
Why?
Drug Hypersensitivity
1
2018
36
0.620
Why?
Anti-Inflammatory Agents
1
2019
162
0.610
Why?
Intestinal Mucosa
1
2019
225
0.600
Why?
Drug Design
1
2018
120
0.600
Why?
Anticonvulsants
1
2018
122
0.580
Why?
Immunoglobulin E
2
2016
92
0.570
Why?
Practice Guidelines as Topic
1
2019
448
0.560
Why?
Food Hypersensitivity
2
2017
100
0.530
Why?
Immune Tolerance
4
2022
95
0.520
Why?
Schnitzler Syndrome
1
2014
4
0.490
Why?
Child
15
2024
6824
0.480
Why?
Interleukin-1beta
1
2014
75
0.460
Why?
Humans
28
2024
49827
0.450
Why?
Peanut Hypersensitivity
3
2022
88
0.450
Why?
Mycobacterium fortuitum
1
2013
6
0.450
Why?
Macrolides
1
2013
16
0.440
Why?
Clarithromycin
1
2013
37
0.430
Why?
Milk Hypersensitivity
2
2024
19
0.430
Why?
Child, Preschool
9
2024
3853
0.420
Why?
Antibodies, Monoclonal
1
2014
458
0.360
Why?
Urticaria
3
2015
18
0.360
Why?
Infant
8
2024
3551
0.350
Why?
Proton Pump Inhibitors
3
2024
84
0.350
Why?
Asthma
2
2023
283
0.340
Why?
Clinical Trials as Topic
2
2022
460
0.320
Why?
Adolescent
6
2019
6340
0.320
Why?
Antibodies, Monoclonal, Humanized
2
2024
222
0.320
Why?
Female
15
2024
26329
0.310
Why?
Treatment Outcome
6
2024
5138
0.300
Why?
Synbiotics
2
2024
3
0.290
Why?
Administration, Oral
3
2022
423
0.270
Why?
Male
13
2024
25093
0.250
Why?
Infant Formula
2
2024
145
0.220
Why?
Amino Acids
2
2024
358
0.220
Why?
Food Supply
1
2023
91
0.210
Why?
Outpatients
1
2023
113
0.210
Why?
Middle Aged
6
2021
11997
0.200
Why?
Adult
7
2023
13160
0.190
Why?
Young Adult
3
2019
3936
0.190
Why?
Injections, Subcutaneous
2
2024
52
0.180
Why?
Follow-Up Studies
3
2024
2179
0.180
Why?
Biological Therapy
1
2019
16
0.180
Why?
Leukocyte Count
1
2019
70
0.170
Why?
Standard of Care
1
2019
16
0.170
Why?
Ulcer
1
2019
22
0.170
Why?
Erythema
1
2019
38
0.170
Why?
Disease Susceptibility
1
2019
89
0.170
Why?
Double-Blind Method
4
2024
674
0.170
Why?
Colon
1
2019
98
0.170
Why?
Intestine, Small
1
2019
109
0.160
Why?
Stomach
1
2019
80
0.160
Why?
Retrospective Studies
3
2019
6117
0.160
Why?
Epinephrine
2
2016
96
0.160
Why?
Hypersensitivity, Immediate
1
2018
11
0.160
Why?
Wiskott-Aldrich Syndrome Protein
1
2018
2
0.160
Why?
Wiskott-Aldrich Syndrome
1
2018
3
0.160
Why?
Forecasting
1
2019
150
0.160
Why?
Disease Management
1
2019
174
0.160
Why?
Combined Modality Therapy
1
2019
636
0.150
Why?
Biopsy
1
2019
582
0.150
Why?
Gastroesophageal Reflux
1
2017
49
0.150
Why?
Particulate Matter
1
2017
52
0.150
Why?
Inflammation
1
2021
604
0.150
Why?
Immunization
1
2017
67
0.150
Why?
Consensus
3
2022
143
0.150
Why?
Comorbidity
1
2019
618
0.140
Why?
Seasons
1
2017
81
0.140
Why?
Deglutition Disorders
1
2017
77
0.140
Why?
Sympathomimetics
1
2016
21
0.140
Why?
Glucocorticoids
1
2018
219
0.140
Why?
Incidence
1
2019
1003
0.130
Why?
Disaccharides
1
2015
11
0.130
Why?
Meat
1
2015
55
0.130
Why?
Environmental Exposure
1
2017
200
0.130
Why?
Flow Cytometry
1
2018
470
0.130
Why?
Cohort Studies
1
2019
1422
0.130
Why?
Prospective Studies
2
2021
2344
0.130
Why?
Longitudinal Studies
1
2017
673
0.130
Why?
Celiac Disease
1
2014
10
0.120
Why?
Hypothyroidism
1
2014
54
0.120
Why?
Fever
1
2014
117
0.110
Why?
Amikacin
1
2013
19
0.110
Why?
Azithromycin
1
2013
25
0.110
Why?
Skin Tests
1
2013
58
0.110
Why?
United States
2
2023
4838
0.110
Why?
Arkansas
1
2017
1967
0.100
Why?
Diagnosis, Differential
1
2014
1036
0.090
Why?
Aged
2
2021
9272
0.090
Why?
Severity of Illness Index
2
2022
942
0.080
Why?
Diabetes Mellitus, Type 2
1
2014
467
0.080
Why?
Infant, Newborn
3
2021
2744
0.070
Why?
Interleukin-13
1
2024
15
0.060
Why?
Interleukin-4
1
2024
43
0.060
Why?
Remission Induction
1
2024
207
0.060
Why?
Cattle
1
2024
210
0.060
Why?
Milk
1
2024
85
0.060
Why?
Spirometry
1
2023
29
0.060
Why?
Nutritional Status
1
2023
140
0.050
Why?
International Cooperation
1
2021
44
0.050
Why?
Electronic Health Records
1
2023
205
0.050
Why?
Health Promotion
1
2023
271
0.050
Why?
Dose-Response Relationship, Drug
1
2024
1374
0.050
Why?
Primary Health Care
1
2023
353
0.040
Why?
Constipation
1
2017
35
0.040
Why?
Vomiting
1
2017
74
0.040
Why?
Diarrhea
1
2017
91
0.040
Why?
Histamine Antagonists
1
2016
19
0.040
Why?
Administration, Cutaneous
1
2016
49
0.030
Why?
Sensitivity and Specificity
1
2018
854
0.030
Why?
Quality of Life
1
2021
833
0.030
Why?
Animals
2
2024
13150
0.030
Why?
Mass Screening
1
2018
351
0.030
Why?
Patient Compliance
1
2016
230
0.030
Why?
Swine
1
2015
391
0.030
Why?
Randomized Controlled Trials as Topic
1
2016
553
0.030
Why?
Pesek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description